Pfizer heads into 2026 with a share price still shaped by the boom and bust of COVID products and a shareholder base that increasingly cares more about income than growth. The company's dividend has ...

Bullish flow in Pfizer (PFE), with shares up 32c, or 1.22%, near $26.18. Options volume running well above average with 250k contracts traded and calls leading puts for a put/call ratio of 0.1, ...

Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might worry ...